Literature DB >> 7877106

Candida albicans, the opportunist. A cellular and molecular perspective.

P F Dupont1.   

Abstract

Candida albicans causes the majority of opportunistic fungal infections. The yeast's commensualistic relationship with humans enables it, when environmental conditions are favorable, to multiply and replace much of the normal flora. Virulence factors of C. albicans, enabling the organism to adhere to and penetrate host tissues, involve specific molecular interactions between the cells of the fungus and the host. Localized disease, such as oral candidiasis, onychomycosis, and vaginitis, results. These infections are usually limited to surfaces of the host, and can be quickly and successfully controlled by the use of one of the available antifungal agents. Candida albicans infections typically become systemic and life threatening when the host is immunocompromised. Depending on the immune defect in the host, one of the spectrum of Candida diseases can develop. If successful treatment of these patients is to be achieved, modulation of the immune deficit, as well as the use of an appropriate antifungal drug, must become a routine part of therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7877106     DOI: 10.7547/87507315-85-2-104

Source DB:  PubMed          Journal:  J Am Podiatr Med Assoc        ISSN: 1930-8264


  18 in total

1.  Induction of the Candida albicans filamentous growth program by relief of transcriptional repression: a genome-wide analysis.

Authors:  David Kadosh; Alexander D Johnson
Journal:  Mol Biol Cell       Date:  2005-04-06       Impact factor: 4.138

Review 2.  Regulatory mechanisms controlling morphology and pathogenesis in Candida albicans.

Authors:  David Kadosh
Journal:  Curr Opin Microbiol       Date:  2019-05-24       Impact factor: 7.934

3.  A 5' UTR-mediated translational efficiency mechanism inhibits the Candida albicans morphological transition.

Authors:  Delma S Childers; Vasanthakrishna Mundodi; Mohua Banerjee; David Kadosh
Journal:  Mol Microbiol       Date:  2014-03-28       Impact factor: 3.501

4.  Identification and characterization of TUP1-regulated genes in Candida albicans.

Authors:  B R Braun; W S Head; M X Wang; A D Johnson
Journal:  Genetics       Date:  2000-09       Impact factor: 4.562

5.  Candida albicans Ume6, a filament-specific transcriptional regulator, directs hyphal growth via a pathway involving Hgc1 cyclin-related protein.

Authors:  Patricia L Carlisle; David Kadosh
Journal:  Eukaryot Cell       Date:  2010-07-23

6.  NRG1, a repressor of filamentous growth in C.albicans, is down-regulated during filament induction.

Authors:  B R Braun; D Kadosh; A D Johnson
Journal:  EMBO J       Date:  2001-09-03       Impact factor: 11.598

7.  Effect of Antifungal Treatment in a Diet-Based Murine Model of Disseminated Candidiasis Acquired via the Gastrointestinal Tract.

Authors:  David Kadosh; Laura K Najvar; Rosie Bocanegra; Marcos Olivo; William R Kirkpatrick; Nathan P Wiederhold; Thomas F Patterson
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

8.  Expression of UME6, a key regulator of Candida albicans hyphal development, enhances biofilm formation via Hgc1- and Sun41-dependent mechanisms.

Authors:  Mohua Banerjee; Priya Uppuluri; Xiang R Zhao; Patricia L Carlisle; Geethanjali Vipulanandan; Cristina C Villar; José L López-Ribot; David Kadosh
Journal:  Eukaryot Cell       Date:  2012-12-07

9.  UME6, a novel filament-specific regulator of Candida albicans hyphal extension and virulence.

Authors:  Mohua Banerjee; Delma S Thompson; Anna Lazzell; Patricia L Carlisle; Christopher Pierce; Carlos Monteagudo; José L López-Ribot; David Kadosh
Journal:  Mol Biol Cell       Date:  2008-01-23       Impact factor: 4.138

10.  Comparative evolution of morphological regulatory functions in Candida species.

Authors:  Erika Lackey; Geethanjali Vipulanandan; Delma S Childers; David Kadosh
Journal:  Eukaryot Cell       Date:  2013-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.